Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP

Watchlist Manager
Tonix Pharmaceuticals Holding Corp Logo
Tonix Pharmaceuticals Holding Corp
NASDAQ:TNXP
Watchlist
Price: 36.05 USD -1.31% Market Closed
Market Cap: 315.4m USD

Wall Street
Price Targets

TNXP Price Targets Summary
Tonix Pharmaceuticals Holding Corp

Wall Street analysts forecast TNXP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TNXP is 62.9 USD with a low forecast of 50.5 USD and a high forecast of 73.5 USD.

Lowest
Price Target
50.5 USD
40% Upside
Average
Price Target
62.9 USD
74% Upside
Highest
Price Target
73.5 USD
104% Upside
Tonix Pharmaceuticals Holding Corp Competitors:
Price Targets
301047
Sino Biological Inc
8% Upside
6955
Shandong Boan Biotechnology Co Ltd
31% Downside
PRLD
Prelude Therapeutics Inc
264% Upside
BCRX
BioCryst Pharmaceuticals Inc
109% Upside
LENZ
Graphite Bio Inc
32% Upside
BCYC
Bicycle Therapeutics PLC
276% Upside
688235
Beigene Ltd
30% Upside
688278
Xiamen Amoytop Biotech Co Ltd
17% Upside

Revenue
Forecast

Revenue Estimate
Tonix Pharmaceuticals Holding Corp

The compound annual growth rate of Tonix Pharmaceuticals Holding Corp's revenue for the next 3 years is 137%.

N/A
Past Growth
137%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Tonix Pharmaceuticals Holding Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
3%
Average Beat

Net Income
Forecast

Net Income Estimate
Tonix Pharmaceuticals Holding Corp

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TNXP's stock price target?
Price Target
62.9 USD

According to Wall Street analysts, the average 1-year price target for TNXP is 62.9 USD with a low forecast of 50.5 USD and a high forecast of 73.5 USD.

What is Tonix Pharmaceuticals Holding Corp's Revenue forecast?
Projected CAGR
137%

The compound annual growth rate of Tonix Pharmaceuticals Holding Corp's revenue for the next 3 years is 137%.

Back to Top